Delivery Order SPE2DB24D2216-SPE2DB25FGPJN
- Not listed
- The Defense Logistics Agency awarded a $1,872.48 delivery order to AmerisourceBergen Drug Corp for Belbuca 600 microgram films (60 count) under a firm fixed price contract type. The award was issued on September 2, 2025, with an ultimate completion date of September 3, 2025, and represents a non-set-aside competitive award. The product will be performed at AmerisourceBergen's facility in Conshohocken, Pennsylvania. This delivery order is a child contract issued under AmerisourceBergen's larger...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,026.43 to AmerisourceBergen Drug Corp for 60 units of Belbuca 750 mcg film, a buprenorphine-based pain management pharmaceutical. Issued on July 31, 2025, with an ultimate completion date of August 1, 2025, this firm fixed-price delivery order was competitively awarded with no set-aside designation. The contract will be performed at AmerisourceBergen Drug Corp's corporate office location in Conshohocken, Pennsylvania....
- The Defense Logistics Agency awarded a delivery order valued at $1,644.43 to AmerisourceBergen Drug Corp for Belbuca 300 mcg film (60 count) on August 14, 2025, with an ultimate completion date of August 15, 2025. This firm fixed-price delivery order, which is not set aside, represents a pharmaceutical supply delivery under the company's larger indefinite delivery contract with DLA Troop Support Medical. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, serves as a...
- The Defense Logistics Agency awarded a $1,168.12 delivery order to AmerisourceBergen Drug Corp for BELBUCA 750 MCG film (60 count) on August 26, 2025, with an ultimate completion date of August 27, 2025. This firm fixed-price delivery order represents a child contract issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. The award was competitively granted with no...
- The Defense Logistics Agency awarded a $2,320.49 delivery order to AmerisourceBergen Drug Corp for BELBUCA 750 MCG Film 60s, a pharmaceutical product used for pain management. This competitively awarded contract, issued on August 25, 2025, carries a firm fixed price and is scheduled for ultimate completion on August 26, 2025. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a child contract under...
- The Defense Logistics Agency awarded a $2,615.72 firm fixed price delivery order to AmerisourceBergen Drug Corp for Belbuca 900 microgram films (60-count units) on September 9, 2025, with an ultimate completion date of September 10, 2025. This non-competitive, non-set-aside award represents a small-value transaction typical of routine pharmaceutical supply replenishment. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, serves as a...
- The Defense Logistics Agency awarded a $1,301.11 delivery order to AmerisourceBergen Drug Corp for the supply of Belbuca 900 mcg film (60 count) under a firm fixed price contract. The order, issued on April 24, 2025, with an ultimate completion date of April 25, 2025, represents a non-set-aside competitive award to support federal pharmaceutical procurement needs. The product will be delivered to the place of performance in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its...
- The Defense Logistics Agency awarded a delivery order valued at $1,061.52 to AmerisourceBergen Drug Corp for BELBUCA 300 MCG Film (60 count) on July 25, 2025, with completion expected by July 28, 2025. This is a firm fixed price, non-set-aside contract executed as a child order under AmerisourceBergen's broader pharmaceutical supply agreements with DLA. The product is a buccal film formulation used for pain management, reflecting the company's role as a critical pharmaceutical distributor for...
- The Defense Logistics Agency awarded a $1,301.28 delivery order to AmerisourceBergen Drug Corp on September 18, 2025, for Belbuca 450 mcg film, with an ultimate completion date of September 19, 2025. This is a firm fixed price, competitively awarded contract with no set-aside designation. Belbuca is a buccal film formulation used for pain management in opioid-tolerant patients. The contract is being performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 15, 2025, for the supply of Belbuca 300 mcg film (60-count), with a ceiling value of $1,075.23. This is a firm fixed-price delivery order with an ultimate completion date of September 16, 2025. The award was made through open competition with no set-aside designation. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will perform this...
- SPE2DB24D2216Indefinite Delivery Contract
- SPE2DB24D2216-SPE2DB25FGPJNDelivery Order
The Defense Logistics Agency issued a delivery order valued at $2,180.68 to AmerisourceBergen Drug Corp for the supply of Belbuca 900 mcg film (60-count package), a buprenorphine transdermal product used for pain management. This competitively awarded, firm fixed price delivery order was placed on August 1, 2025, with an ultimate completion date of August 4, 2025. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026, which serves as a comprehensive global pharmaceutical support vehicle for military healthcare systems. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, is well-positioned to fulfill this federal medical procurement requirement as a critical vendor for military and veteran healthcare systems. The company's extensive federal contract portfolio demonstrates its capability to supply a comprehensive range of pharmaceutical products and medical supplies across multiple therapeutic domains. This delivery order supports DLA's medical supply chain operations and contributes to the broader federal objective of ensuring adequate pharmaceutical inventory for military healthcare programs worldwide.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.2k | 8/1/25 |